Proteus Digital Health Stock

Digital health products

Sign up today and learn more about Proteus Digital Health Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Harbin Gloria Pharmaceuticals


Redwood City CA, US

Total Funding


About Proteus Digital Health Stock

Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.


Funding History

May 2001$750K
December 2003$11.0M
May 2006$34.0M
October 2008$32.1M
December 2009$35.0M
May 2013$85.8M
July 2014$201M
April 2016$111M


Co-Founder & Chief Executive Officer

Andrew Thompson

Co-Founder & Chief Medical Officer

George Savage, M.D.

Co-Founder & Chief Technologist

Mark Zdeblick, Ph.D.

Chief Platform Officer

David O'Reilly


medcitynews - Jan, 31 2020

Will Proteus’ pivot pay off?

strictlyvc - Apr, 30 2016

StrictlyVC: April 19, 2016

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: